Modified Leukocyte IG-like receptor family members (LIR's) with increased affinity for class I MHC and their uses in modulating T cell activation

Details for Australian Patent Application No. 2006250976 (hide)

Owner Medigene Limited

Inventors Moysey, Ruth Karen; Li, Yi; Jakobsen, Bent Karsten

Agent Davies Collison Cave

Pub. Number AU-A-2006250976

PCT Pub. Number WO2006/125963

Priority 0510627.3 25.05.05 GB

Filing date 19 May 2006

Wipo publication date 30 November 2006

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (1970.01) Medicinal preparations containing peptides - from animals

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

6 December 2007 PCT application entered the National Phase

  PCT publication WO2006/125963 Priority application(s): WO2006/125963

17 February 2011 Assignment before Grant

  Medigene Limited The application has been assigned to MediGene AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006250977-A process for the dynamic resolution of (substituted) (R) - or (S) -mandelic acid

2006250972-Water turbine with bi-symmetric airfoil